136 related articles for article (PubMed ID: 8106968)
1. Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS).
Saah AJ; Hoover DR; He Y; Kingsley LA; Phair JP
J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):287-95. PubMed ID: 8106968
[TBL] [Abstract][Full Text] [Related]
2. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
[TBL] [Abstract][Full Text] [Related]
3. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993.
Osmond D; Charlebois E; Lang W; Shiboski S; Moss A
JAMA; 1994 Apr; 271(14):1083-7. PubMed ID: 7908703
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
5. Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study.
Saah AJ; Muñoz A; Kuo V; Fox R; Kaslow RA; Phair JP; Rinaldo CR; Detels R; Polk BF
Am J Epidemiol; 1992 May; 135(10):1147-55. PubMed ID: 1352940
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with survival following secondary AIDS: 1988 to 1995.
Huang H; Chmiel JS; Detels R; Hoover DR; Muñoz A
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):495-504. PubMed ID: 9715847
[TBL] [Abstract][Full Text] [Related]
7. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
[TBL] [Abstract][Full Text] [Related]
9. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.
Graham NM; Zeger SL; Park LP; Phair JP; Detels R; Vermund SH; Ho M; Saah AJ
Lancet; 1991 Aug; 338(8762):265-9. PubMed ID: 1677108
[TBL] [Abstract][Full Text] [Related]
10. CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time.
Graham NM; Piantadosi S; Park LP; Phair JP; Rinaldo CR; Fahey JL
J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1258-66. PubMed ID: 7901384
[TBL] [Abstract][Full Text] [Related]
11. Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities.
Holmberg SD; Conley LJ; Buchbinder SP; Judson FN; Bush TJ; Katz MH; Penley KA; Hershow RC
AIDS; 1993 May; 7(5):699-704. PubMed ID: 8318177
[TBL] [Abstract][Full Text] [Related]
12. Thrush and fever as measures of immunocompetence in HIV-1-infected men.
Kirby AJ; Muñoz A; Detels R; Armstrong JA; Saah A; Phair JP
J Acquir Immune Defic Syndr (1988); 1994 Dec; 7(12):1242-9. PubMed ID: 7965635
[TBL] [Abstract][Full Text] [Related]
13. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men.
Tang AM; Graham NM; Kirby AJ; McCall LD; Willett WC; Saah AJ
Am J Epidemiol; 1993 Dec; 138(11):937-51. PubMed ID: 7903021
[TBL] [Abstract][Full Text] [Related]
14. Survival and treatment of AIDS patients 1984-1993: experience of a smaller east London HIV centre.
Hillman RJ; Beck EJ; Mandalia S; Satterthwaite H; Rogers PA; Forster GE; Goh BT
Genitourin Med; 1997 Feb; 73(1):44-8. PubMed ID: 9155555
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.
Detels R; Muñoz A; McFarlane G; Kingsley LA; Margolick JB; Giorgi J; Schrager LK; Phair JP
JAMA; 1998 Nov; 280(17):1497-503. PubMed ID: 9809730
[TBL] [Abstract][Full Text] [Related]
16. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M
Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225
[TBL] [Abstract][Full Text] [Related]
17. Gender and survival after AIDS in Rio de Janeiro, Brazil.
Santoro-Lopes G; Harrison LH; Moulton LH; Lima LA; de Pinho AM; Hofer C; Schechter M
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):403-7. PubMed ID: 9833750
[TBL] [Abstract][Full Text] [Related]
18. Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection.
Phillips AN; Sabin CA; Elford J; Bofill M; Janossy G; Lee CA
BMJ; 1994 Jul; 309(6950):309-13. PubMed ID: 7916226
[TBL] [Abstract][Full Text] [Related]
19. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
[TBL] [Abstract][Full Text] [Related]
20. Access to therapy in the Multicenter AIDS Cohort Study, 1989-1992.
Graham NM; Jacobson LP; Kuo V; Chmiel JS; Morgenstern H; Zucconi SL
J Clin Epidemiol; 1994 Sep; 47(9):1003-12. PubMed ID: 7730902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
